Top Bioprocessing Companies
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Bioprocessing Companies
Bioprocessing News
Boosting Laboratory Accuracy: How Proficiency Testing Shapes the Future of Life Sciences
Friday, September 11, 2026
Life science proficiency testing service providers have emerged as indispensable components in the quality control process for all research laboratories, diagnostic laboratories, pharmaceutical companies, biotech firms, and regulatory bodies. Given that scientific activity has been increasing in complexity, there is a need for laboratories to have reliable mechanisms for measuring their analytical performance and validating test accuracy. The process of proficiency testing involves conducting independent evaluations through comparison to standards and other laboratories. Organizations that make use of proficiency testing services are showing their dedication towards quality mana
Clinical Laboratories Become a Strategic Driver of Modern Healthcare
Thursday, September 10, 2026
Clinical laboratories have always played an essential role in healthcare, but their influence now reaches far beyond test results. Every diagnosis, treatment plan and disease monitoring strategy depends on reliable laboratory data. What was once viewed primarily as a support function has become a critical contributor to clinical decision-making across the healthcare system. That shift is changing how healthcare organizations invest in laboratory capabilities. Hospitals, health systems and independent laboratories face growing demand for faster turnaround times, greater testing capacity and increasingly complex diagnostic services. Rising rates of chronic disease, an aging popula
Advancing Acute Bleeding Medicine Development through Faster Hemostatic Therapies
Tuesday, September 08, 2026
Fremont, CA: Severe bleeding remains one of the most urgent medical emergencies across hospitals, trauma centers, surgical units and emergency care settings. Every minute matters because rapid blood loss can quickly reduce oxygen delivery to vital organs and increase the risk of long-term complications. Healthcare providers continue to seek treatments that stop bleeding faster while supporting recovery with fewer adverse effects. This growing focus has placed greater emphasis on the development of acute bleeding medicines as researchers and pharmaceutical companies work to improve outcomes through innovative hemostatic therapies. Hemostasis is the body's nat
Choosing an ADC and AOC CDMO Partner for Complex Bioconjugates
Monday, August 24, 2026
Few development decisions carry greater downstream consequences than selecting a CDMO for antibody-drug conjugates (ADCs) and antibody-oligonucleotide conjugates (AOCs). Scientific promise alone rarely determines whether a program reaches the clinic on schedule. Process transfer delays, fragmented development ownership and manufacturing approaches that fail to scale often become the larger sources of cost and timeline risk. For emerging biotechnology companies working against limited funding windows, every additional handoff introduces another opportunity for delay. Many organizations still assemble development programs across several specialized providers. One partner may suppo
The State of the Regulatory and Compliance Industry: Business Oversight Takes on a Larger Strategic Role
Thursday, August 20, 2026
Regulatory and compliance programs have become an essential part of modern business management. Organizations face an expanding mix of privacy laws, cybersecurity requirements, financial regulations and industry-specific rules that demand continuous attention. Compliance now supports far more than legal obligations. Strong governance helps businesses protect their reputation, reduce risk and maintain confidence among customers, investors and regulators. Business leaders operate in an environment where regulatory expectations continue to evolve. Financial institutions, healthcare providers, manufacturers and government agencies often manage multiple compliance obligations across
Advancing Targeted Therapies with Next Generation ADC and AOC CDMO Solutions
Wednesday, August 19, 2026
The field of targeted therapy development is evolving rapidly as pharmaceutical and biotechnology companies pursue more precise treatments for complex diseases. Antibody drug conjugates and antibody oligonucleotide conjugates are reshaping the therapeutic landscape by combining selective targeting with advanced payload delivery. This shift has increased the importance of specialized contract development and manufacturing organizations that can support the intricate processes involved in ADC and AOC production. Modern drug developers are seeking partners with deep expertise in bioconjugation chemistry, analytical development process optimization and regulatory support. The comple
